Qi Zhu
Chief Tech/Sci/R&D Officer at CUTIA THERAPEUTICS
Profile
Qi Zhu is currently the Director-Medical Affair at Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd.
and the Chief Medical Officer at Cutia Therapeutics since 2019.
Previously, he worked as the Director-Medical Affair at AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd.
from 2013 to 2015.
Mr. Zhu holds an MBA from Shanghai University of Finance & Economics, an undergraduate degree from Shanghai University, and a graduate degree from Shanghai University.
Qi Zhu active positions
| Companies | Position | Start |
|---|---|---|
| CUTIA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 08/09/2019 |
| Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. | Chief Tech/Sci/R&D Officer | - |
Former positions of Qi Zhu
| Companies | Position | End |
|---|---|---|
| AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | Corporate Officer/Principal | 31/08/2015 |
Training of Qi Zhu
| Shanghai University | Undergraduate Degree |
| Shanghai University of Finance & Economics | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CUTIA THERAPEUTICS | Health Technology |
| Private companies | 2 |
|---|---|
| Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. | |
| AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. |
- Stock Market
- Insiders
- Qi Zhu
